Aphria Inc. (TSX: APH) (OTC: APHQF) presented this morning to the public the company’s portfolio of cannabis brands that it plans to launch for the upcoming recreational market in Canada. The company has researched these five cannabis brands over the course of the past few years. Aphria has conducted focus groups and developed a portfolio consisting of a variety of different products featuring a spectrum of different price points.
The five new Aphria brands are the following:
Broken Coast Cannabis
Aphria purchased Broken Coast Cannabis last January for an estimated C$230 million dollars. The indoor cannabis cultivation company became Aphria’s wholly-owned subsidiary which gave the company the addition of an award winning and trusted cannabis brand to its portfolio. Broken Coast cultivates cannabis in small batches utilizing carefully chosen strains.
Solei Sungrown Cannabis (“Solei”)
Solei is a company that cultivates cannabis via a unique greenhouse grow system utilizing natural, safe, and eco-friendly growing practices. The company will sell a variety of different THC strains and derived products, as well as, a CBD based products.
Riff will produce and develop high potency cannabis products for experienced users.
Good Supply will be offering cannabis and cannabis derived products at an affordable rate for everyday cannabis users.
Goodfields is being developed as an entry point for new cannabis users interested in quality cannabis from a trusted source, cultivated with care.
“I’m incredibly proud of our product development, manufacturing and marketing teams for their passion, hard work and dedication to developing brands that we are confident will resonate with consumers across a broad range of distinct segments,” said Vic Neufeld, Chief Executive Officer of Aphria.
You may be interested
Global Hemp Group Announces Harvest Update on their CBD Hemp Farm in Scio OregonEditor - November 27, 2018
Vancouver, BC -- (November 27, 2018) -- GLOBAL HEMP GROUP INC. (“GHG” or the “Company”) (CSE: GHG / OTC: GBHPF / FRANKFURT: GHG) and its joint venture…
Wayland Group Enters UK Cannabis Market with Theros Pharma AcquisitionEditor - November 26, 2018
Wayland Group (CSE:WAYL) (OTCQB:MRRCF) has announced this morning that their company has entered into an agreement to acquire 51% of UK company Theros Pharma Ltd. The Wayland Group…
GW Pharma’s CBD Pharmaceutical, Epidiolex, Shows Results in Lowering Seizures in Clinical TrialsEditor - November 26, 2018
GW Pharmaceuticals (Nasdaq: GWPH) has announced this morning that their company has completed a double-blind, placebo-controlled Phase 3 clinical trial for its Cannabidiol (CBD) derived product EPIDIOLEX®.…